Combination with carboplatin and paclitaxel in patients. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Tumor Cells, Cultured Microtubules

Organisms2

Taxus Mice, Nude

Diseases42

Ovarian Neoplasms Lung Neoplasms Carcinoma, Non-Small-Cell Lung Thrombocytopenia Neutropenia Fallopian Tube Neoplasms Leukopenia Hematologic Diseases Neoplasms Retinal Neoplasms Peritoneal Neoplasms Breast Neoplasms Carcinoma, Small Cell Retinoblastoma Drug Hypersensitivity Neoplasm Recurrence, Local Carcinoma Neoplasms, Glandular and Epithelial Nausea Peripheral Nervous System Diseases Germinoma Testicular Neoplasms Alopecia Seminoma Neoplasms, Germ Cell and Embryonal Adenocarcinoma Neoplasms, Unknown Primary Urologic Neoplasms Genital Neoplasms, Female Vomiting Head and Neck Neoplasms Disease Progression Cystadenocarcinoma, Serous Carcinoma, Squamous Cell Brain Neoplasms Carcinoma, Large Cell Bone Marrow Diseases Adenocarcinoma, Bronchiolo-Alveolar Agranulocytosis Anemia Endometrial Neoplasms Carcinoma, Transitional Cell

Chemicals and Drugs46

Carboplatin Paclitaxel Antineoplastic Agents, Phytogenic Cisplatin Antineoplastic Agents Etoposide Platinum Ifosfamide Taxoids Deoxycytidine Organoplatinum Compounds Doxorubicin Topotecan Vinblastine Thiotepa Amifostine Tubulin Modulators Cyclophosphamide Bridged Compounds Epothilones Antibodies, Monoclonal, Humanized Epirubicin Isocoumarins Platinum Compounds Tubulin Estramustine Granulocyte Colony-Stimulating Factor P-Glycoprotein Mesna Fluorouracil Guanine Pharmaceutical Vehicles Glutamates Polyethylene Glycols Antibodies, Monoclonal Radiation-Sensitizing Agents Albumins Vincristine Camptothecin Folic Acid Transporters Quinazolines Triethylenephosphoramide Antineoplastic Agents, Alkylating Drug Carriers Cyclosporins Polyglutamic Acid

Analytical, Diagnostic and Therapeutic Techniques and Equipment33

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Infusions, Intravenous Treatment Outcome Area Under Curve Combined Modality Therapy Maximum Tolerated Dose Disease-Free Survival Survival Analysis Neoplasm Staging Survival Rate Feasibility Studies Drug Screening Assays, Antitumor Drug Evaluation Chemotherapy, Adjuvant Salvage Therapy Remission Induction Pharmaceutical Vehicles Xenograft Model Antitumor Assays Kaplan-Meier Estimate Drug Delivery Systems Early Termination of Clinical Trials Administration, Oral Dose Fractionation Prognosis Infusions, Parenteral Hyperthermia, Induced Follow-Up Studies Transplantation, Autologous Chemoradiotherapy Drug Carriers Inhibitory Concentration 50 Hematopoietic Stem Cell Transplantation

Phenomena and Processes11

Area Under Curve Dose-Response Relationship, Drug Maximum Tolerated Dose Drug Resistance, Neoplasm Drug Synergism Apoptosis Time Factors Drug Interactions Cell Survival Drug Resistance, Multiple Inhibitory Concentration 50

Anthropology, Education, Sociology and Social Phenomena2

Survival Quality of Life

Technology, Industry, Agriculture2

Polyethylene Glycols Nanoparticles

Humanities1

Quality of Life

Information Science1

Health Care9

Treatment Outcome Area Under Curve Disease-Free Survival Survival Analysis Survival Rate Feasibility Studies Kaplan-Meier Estimate Early Termination of Clinical Trials Follow-Up Studies

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care

Carboplatin Paclitaxel Antineoplastic Combined Chemotherapy Protocols Antineoplastic Agents, Phytogenic Ovarian Neoplasms Drug Administration Schedule Cisplatin Lung Neoplasms Antineoplastic Agents Carcinoma, Non-Small-Cell Lung Infusions, Intravenous Treatment Outcome Etoposide Platinum Ifosfamide Area Under Curve Thrombocytopenia Combined Modality Therapy Dose-Response Relationship, Drug Neutropenia Maximum Tolerated Dose Disease-Free Survival Taxoids Deoxycytidine Fallopian Tube Neoplasms Organoplatinum Compounds Drug Resistance, Neoplasm Survival Analysis Leukopenia Neoplasm Staging Survival Rate Doxorubicin Hematologic Diseases Topotecan Neoplasms Retinal Neoplasms Vinblastine Peritoneal Neoplasms Thiotepa Breast Neoplasms Amifostine Tubulin Modulators Cyclophosphamide Drug Synergism Carcinoma, Small Cell Bridged Compounds Retinoblastoma Cell Line, Tumor Drug Hypersensitivity Epothilones Neoplasm Recurrence, Local Antibodies, Monoclonal, Humanized Carcinoma Neoplasms, Glandular and Epithelial Epirubicin Isocoumarins Nausea Platinum Compounds Feasibility Studies Peripheral Nervous System Diseases Drug Screening Assays, Antitumor Germinoma Drug Evaluation Testicular Neoplasms Chemotherapy, Adjuvant Salvage Therapy Alopecia Seminoma Remission Induction Neoplasms, Germ Cell and Embryonal Adenocarcinoma Tubulin Neoplasms, Unknown Primary Taxus Estramustine Urologic Neoplasms Genital Neoplasms, Female Granulocyte Colony-Stimulating Factor Vomiting P-Glycoprotein Mesna Tumor Cells, Cultured Fluorouracil Mice, Nude Head and Neck Neoplasms Disease Progression Cystadenocarcinoma, Serous Guanine Apoptosis Pharmaceutical Vehicles Glutamates Xenograft Model Antitumor Assays Kaplan-Meier Estimate Time Factors Polyethylene Glycols Carcinoma, Squamous Cell Drug Delivery Systems Antibodies, Monoclonal Radiation-Sensitizing Agents Early Termination of Clinical Trials

No FAQ available that match "combination with carboplatin and paclitaxel in patients"